secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apyx Medical Corp (APYX)
CIK:        0000719135
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0000719135-23-000054
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apyx Medical Q3 revenue up 31% to $12.0M; cuts FY2023 revenue guidance sharply
------------------------------------------------------------------------------

- Q3 Advanced Energy revenue $9.8M (+39%); total revenue $12.0M (+31%); net loss $4.6M improved 20% YoY.
- Cuts FY2023 revenue guidance to $53-54M from $59-62M; Advanced Energy now $44.5-45.5M from $51-54M.
- Secured $45M credit facility with Perceptive; initial $37.5M funded; used to repay MidCap debt.
- CFO Tara Semb to leave; successor identified but not named; departure not due to disagreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/719135/000071913523000054/0000719135-23-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/719135/000071913523000054/apyx-20231109.htm
  HTML page:      https://secwatch.observer/filing/0000719135-23-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer